European Commission logo
English English
CORDIS - EU research results

The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance

Project description

Profiling the messengers that cancer cells use to spread more than their word

In recent years, extracellular vesicles (EVs) have risen from relative obscurity to stardom. They are secreted by all cells and are now recognised as the carriers of biologically active molecules that travel to local or distant targets to mediate cell-cell communication. Cancer progression and metastasis is linked to EVs as these cells use EVs to export regulatory molecules like oncoproteins and oncopeptides. Further, EVs are found in bodily fluids, supporting their potential as blood-based or urine-based biomarkers as well as targets for cancer therapies. proEVLifeCycle is creating a dynamic team of researchers to enhance understanding of the lifecycle of EVs involved in prostate cancer to improve diagnosis and treatment of the most common cancer in men.


The prostate cancer Extracellular Vesicle LifeCycle (proEVLifeCycle) network is an innovative, multidisciplinary training
program focused on understanding the biology, biomarker potential and function of extracellular vesicles (EVs) to resolve
unmet clinical needs of prostate cancer (PCa). It is within this realm, that we will equip early stage researchers with the
knowledge, tools and a creative ethos to be independent scientists, leaders, and drivers of innovation. The lifecycle of EVs is
poorly understood and their potential as non-invasive biomarkers and therapy target/agents, a growing area of interest. This
research can perfectly be integrated with the high need for novel biomarkers and therapy targets for PCa. Any relief in the
burden of this disease will have major impact on the huge socio-economic problems for patients, families, caregivers and
The ambitious scientific objectives are to unravel the mysteries of EV biogenesis, homing and uptake to explain how vesicles
operate in disease processes; their heterogeneity, their molecular complexity, the biological functions they drive, their local
and systemic dissemination and how these may be manipulated. Using state-of-the-art, network-wide shared model
systems, imaging and profiling tools, and systems biology, the program will enlighten the lifecycle of EVs and identify novel
EV biomarkers and PCa therapy targets to address the unmet clinical needs.
Our original network of 7 academic and 3 company beneficiaries and 11 partners, provides optimal scientific training, crosssectoral
awareness, entrepreneurship skills, communication in the modern age, extensive opportunities for mobility and
patient-facing experiences. We herein meet identified EU-skills gaps providing well-rounded and inventive experts primed for influential careers, contributing to patient well-being and economic prosperity within the EU.


Net EU contribution
€ 265 619,88
3015 GD Rotterdam

See on map

West-Nederland Zuid-Holland Groot-Rijnmond
Activity type
Higher or Secondary Education Establishments
Total cost
€ 265 619,88

Participants (9)